| Mepha Pharma AG - Mirtazapin-Mepha Teva 30 mg, Filmtabletten | | 61460 | | 02 | | Mirtazapin-Mepha Teva 30 mg | | Filmtabletten | | N06AX11 | | Mirtazapine | | 06.09.2011 | | |
| | Composition | | mirtazapinum 30 mg, lactosum monohydricum 203.6 mg, amylum pregelificatum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 0.52 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 8000, E 172 (flavum), E 172 (rubrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Mirtazapine | 30 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 203.6 mg | | | Macrogol | 8000 | | | | | | | | | | | Silica Colloidalis Anhydrica | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 013 | 10 | PR | PR | B | | Yes | | 014 | 30 | PR | PR | B | | Yes | | 015 | 100 | PR | PR | B | | Yes |
|
|
